MFN2 and Charcot-Marie-Tooth disease type 2A1: These indicate that although heterozygous expression of the Mfn2K357T mutation altered mitochondrial dynamics and possibly other Mfn2-mediated functions, it was not sufficient to trigger a full CMT2A phenotype, even after LPS administration.